Stephen S. Yoder
Overview
Stephen S. Yoder received an average of $2M in total compensation, including $459K in salary, at Pieris Pharmaceuticals from 2014 to 2023.
2023Pieris PharmaceuticalsChief Executive Officer
2022Pieris PharmaceuticalsChief Executive Officer
2019Pieris PharmaceuticalsChief Executive Officer
2018Pieris PharmaceuticalsChief Executive Officer
2017Pieris PharmaceuticalsChief Executive Officer
2016Pieris PharmaceuticalsChief Executive Officer, President
2015Pieris PharmaceuticalsChief Executive Officer, President
2014Pieris PharmaceuticalsChief Executive Officer, President
Source: SEC filings on November 6, 2024, April 28, 2020, June 18, 2019, June 14, 2018, May 16, 2017, and May 31, 2016.
Related executives
We found seven more executives who work or worked at Pieris Pharmaceuticals.
Thomas Bures
Pieris Pharmaceuticals
Chief Financial Officer
Shane Olwill
Pieris Pharmaceuticals
Former Senior Vice President and Chief Development Officer
Hitto Kaufmann
Pieris Pharmaceuticals
Chief Scientific Officer
Louis Matis
Pieris Pharmaceuticals
Chief Development Officer
Allan Reine
Pieris Pharmaceuticals
Chief Financial Officer
Claude Knopf
Pieris Pharmaceuticals
Former Chief Business Officer
Darlene Deptula-Hicks
Pieris Pharmaceuticals